A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1007/s10549-023-07073-0
dc.identifier.other
WOS:001081072700001
dc.description.volume
dc.description.issue
Publisher
SPRINGER
DOI
10.1007/s10549-023-07073-0